Pulmonary drug delivery to older people

Adv Drug Deliv Rev. 2018 Oct:135:50-61. doi: 10.1016/j.addr.2017.11.010. Epub 2017 Nov 29.

Abstract

Pulmonary diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are common in older people. Treatment principles are well established in this group of patients; however, inadequate training and improper inhaler techniques often results in poor treatment outcomes. Healthcare professionals often do not have the required knowledge about the most common inhaler devices. Age-related conditions like cognitive ability and physical strength would also impact on the inhaler usage. Pharmacokinetics and pharmacodynamics may be affected by physiological changes, like impaired renal and hepatic functions and reduced lung functions. Adjusting and optimizing the inhaler device to the patient preferences, improvement of the drug formulation and inhalers, and using different adherence strategies might improve the treatment outcomes in elderly patients.

Keywords: Elderly patients; Inhalation drug delivery; Inhaler devices; Medication adherence strategies; Pharmacokinetics and pharmacodynamics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Asthma / drug therapy*
  • Asthma / metabolism
  • Drug Compounding
  • Drug Delivery Systems*
  • Humans
  • Nebulizers and Vaporizers
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / metabolism